These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 21047997

  • 1. Intranasal vaccination with chitosan-DNA nanoparticles expressing pneumococcal surface antigen a protects mice against nasopharyngeal colonization by Streptococcus pneumoniae.
    Xu J, Dai W, Wang Z, Chen B, Li Z, Fan X.
    Clin Vaccine Immunol; 2011 Jan; 18(1):75-81. PubMed ID: 21047997
    [Abstract] [Full Text] [Related]

  • 2. Mucosal immunization with PsaA protein, using chitosan as a delivery system, increases protection against acute otitis media and invasive infection by Streptococcus pneumoniae.
    Xu JH, Dai WJ, Chen B, Fan XY.
    Scand J Immunol; 2015 Mar; 81(3):177-85. PubMed ID: 25565478
    [Abstract] [Full Text] [Related]

  • 3. Induction of systemic and mucosal immune response and decrease in Streptococcus pneumoniae colonization by nasal inoculation of mice with recombinant lactic acid bacteria expressing pneumococcal surface antigen A.
    Oliveira ML, Arêas AP, Campos IB, Monedero V, Perez-Martínez G, Miyaji EN, Leite LC, Aires KA, Lee Ho P.
    Microbes Infect; 2006 Apr; 8(4):1016-24. PubMed ID: 16549380
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Immunoprotective effect of combined pneumococcal endopeptidase O and pneumococcal surface adhesin A vaccines against Streptococcus pneumoniae infection].
    Zhang J, Cui YL, Jiang YM.
    Zhongguo Dang Dai Er Ke Za Zhi; 2017 May; 19(5):583-589. PubMed ID: 28506354
    [Abstract] [Full Text] [Related]

  • 8. Enhanced safety and immunogenicity of a pneumococcal surface antigen A mutant whole-cell inactivated pneumococcal vaccine.
    David SC, Laan Z, Minhas V, Chen AY, Davies J, Hirst TR, McColl SR, Alsharifi M, Paton JC.
    Immunol Cell Biol; 2019 Sep; 97(8):726-739. PubMed ID: 31050022
    [Abstract] [Full Text] [Related]

  • 9. Intranasal Immunization with the Commensal Streptococcus mitis Confers Protective Immunity against Pneumococcal Lung Infection.
    Shekhar S, Khan R, Schenck K, Petersen FC.
    Appl Environ Microbiol; 2019 Mar 15; 85(6):. PubMed ID: 30683742
    [Abstract] [Full Text] [Related]

  • 10. Mucosal immunization with polyamine transport protein D (PotD) protects mice against nasopharyngeal colonization with Streptococcus pneumoniae.
    Shah P, Briles DE, King J, Hale Y, Swiatlo E.
    Exp Biol Med (Maywood); 2009 Apr 15; 234(4):403-9. PubMed ID: 19176871
    [Abstract] [Full Text] [Related]

  • 11. Comparison of four adjuvants revealed the strongest protection against lethal pneumococcal challenge following immunization with PsaA-PspA fusion protein and AS02 as adjuvant.
    Chen X, Li B, Yu J, Zhang Y, Mo Z, Gu T, Kong W, Zhang Y, Wu Y.
    Med Microbiol Immunol; 2019 Apr 15; 208(2):215-226. PubMed ID: 30707297
    [Abstract] [Full Text] [Related]

  • 12. Preparation and immunogenicity of capsular polysaccharide-surface adhesin A (PsaA) conjugate of Streptococcuspneumoniae.
    Lin H, Lin Z, Meng C, Huang J, Guo Y.
    Immunobiology; 2010 Jul 15; 215(7):545-50. PubMed ID: 19880214
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Th17/Th1 biased immunity to the pneumococcal proteins PcsB, StkP and PsaA in adults of different age.
    Schmid P, Selak S, Keller M, Luhan B, Magyarics Z, Seidel S, Schlick P, Reinisch C, Lingnau K, Nagy E, Grubeck-Loebenstein B.
    Vaccine; 2011 May 23; 29(23):3982-9. PubMed ID: 21481328
    [Abstract] [Full Text] [Related]

  • 17. Relationship between surface accessibility for PpmA, PsaA, and PspA and antibody-mediated immunity to systemic infection by Streptococcus pneumoniae.
    Gor DO, Ding X, Briles DE, Jacobs MR, Greenspan NS.
    Infect Immun; 2005 Mar 23; 73(3):1304-12. PubMed ID: 15731027
    [Abstract] [Full Text] [Related]

  • 18. Increased protection against pneumococcal disease by mucosal administration of conjugate vaccine plus interleukin-12.
    Lynch JM, Briles DE, Metzger DW.
    Infect Immun; 2003 Aug 23; 71(8):4780-8. PubMed ID: 12874361
    [Abstract] [Full Text] [Related]

  • 19. Protection against nasal colonization with Streptococcus pneumoniae by parenteral immunization with a DNA vaccine encoding PspA (Pneumococcal surface protein A).
    Ferreira DM, Oliveira ML, Moreno AT, Ho PL, Briles DE, Miyaji EN.
    Microb Pathog; 2010 Jun 23; 48(6):205-13. PubMed ID: 20206678
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.